Product NDC: | 53489-110 |
Proprietary Name: | Carisoprodol |
Non Proprietary Name: | Carisoprodol |
Active Ingredient(s): | 350 mg/1 & nbsp; Carisoprodol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53489-110 |
Labeler Name: | Mutual Pharmaceutical Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089346 |
Marketing Category: | ANDA |
Start Marketing Date: | 19911017 |
Package NDC: | 53489-110-05 |
Package Description: | 500 TABLET in 1 BOTTLE, PLASTIC (53489-110-05) |
NDC Code | 53489-110-05 |
Proprietary Name | Carisoprodol |
Package Description | 500 TABLET in 1 BOTTLE, PLASTIC (53489-110-05) |
Product NDC | 53489-110 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Carisoprodol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19911017 |
Marketing Category Name | ANDA |
Labeler Name | Mutual Pharmaceutical Company, Inc. |
Substance Name | CARISOPRODOL |
Strength Number | 350 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |